The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Levels of circulating natural killer T and natural killer cells in breast cancer patients.
Mya Sanda Thein
No relevant relationships to disclose
Saranya Chumsri
No relevant relationships to disclose
James Eeast
No relevant relationships to disclose
Junxin Li
No relevant relationships to disclose
Susan Kesmodel
No relevant relationships to disclose
Ting Bao
No relevant relationships to disclose
Steven J. Feigenberg
No relevant relationships to disclose
Katherine Hanna Tkaczuk
No relevant relationships to disclose
Tonya Webb
No relevant relationships to disclose